Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 28, Issue 4, Pages 209-224
http://dx.doi.org/10.3233/DMA-2010-0707

Systems Biology Approaches to Disease Marker Discovery

Donald Sharon,1 Rui Chen,2 and Michael Snyder2

1Department of Molecular, Cellular and Developmental Biology, Yale University, New Haven, CT, USA
2Department of Genetics, Stanford University School of Medicine, Stanford, CA, USA

Received 31 May 2010; Accepted 31 May 2010

Copyright © 2010 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Our understanding of human disease and potential therapeutics is improving rapidly. In order to take advantage of these developments it is important to be able to identify disease markers. Many new high-throughput genomics and proteomics technologies are being implemented to identify candidate disease markers. These technologies include protein microarrays, next-generation DNA sequencing and mass spectrometry platforms. Such methods are particularly important for elucidating the repertoire of molecular markers in the genome, transcriptome, proteome and metabolome of patients with diseases such as cancer, autoimmune diseases, and viral infections, resulting from the disruption of many biological pathways. These new technologies have identified many potential disease markers. These markers are expected to be valuable to achieve the promise of truly personalized medicine.